A Daily Network publication
Explore the network
Private Wealth Daily
Independent Intelligence on the Private Wealth Industry
Friday, October 2, 2026The Morning Brief →Sign in
PTHInvescoINDEX

Invesco DWA Healthcare Momentum ETF

$59.66-1.81% vs prior close
446452-WK

Price through Sep 30 · Flows through Sep 29. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.

Price & daily flows
59.854.248.559.66DAILY NET FLOWOct 1Jan 30Jun 1Oct 1

SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN · NET +$225M OVER THIS RANGE

The desk’s read

Money keeps arriving — +$99M of net inflows over the past month, about 27.0% of the fund's asset base, while the price has returned +20.0% so far this year. At 0.60% a year it is not the cheapest way in — FDHT has a reported fee of 0.39%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$367Massets under management
0.60%expense ratio · $60 per $10,000 a year
+$99Mnet flow, trailing month
47Kavg daily volume, 30 days
60holdings · US-domiciled
2006listed October 11, 2006 · beta 0.98
The book at a glance
MRNA-1.9%RVMD+0.3%GH-2.0%ROIV-2.9%TXG-1.8%BTSG+0.9%AXSM-1.3%TWST-2.7%ILMN-2.9%ORKA+0.2%ERAS-0.5%REPL+1.6%RLAY+2.4%TVTX-3.4%OSCR-3.0%AXGN-4.8%TNGX-2.0%AGL+3.4%HUM-0.5%SYRE+1.0%LGND-3.1%VTRS-1.5%JAZZ+0.6%CNC-1.8%CORT-1.0%HIMS-1.6%CYTK-0.4%ARWR-1.0%ARQT-4.3%EXEL-0.8%ELVN+0.8%ABSI-0.2%MBX-3.5%NEO-3.2%AMRX-0.3%PACS-1.3%KRYS-2.2%NHCTGTXVCYT

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

HoldingsDownload CSV
#HoldingWeightPriceDay52-wk
1MRNAMODERNA6.35%$188.94-1.9%
2RVMDREVOLUTION MEDICINES5.16%$205.89+0.3%
3GHGUARDANT HEALTH5.23%$174.75-2.0%
4ROIVROIVANT SCIENCES5.09%$35.50-2.9%
5TXG10X GENOMICS4.14%$88.76-1.8%
6BTSGBRIGHTSPRING HEALTH SERVICES INC3.65%$57.26+0.9%
7AXSMAXSOME THERAPEUTICS3.33%$182.07-1.3%
8TWSTTWIST BIOSCIENCE3.20%$188.05-2.7%
9ILMNILLUMINA2.65%$265.72-2.9%
10ORKAOruka Therapeutics2.25%$83.42+0.2%
11ERASERASCA2.26%$14.58-0.5%
12REPLREPLIMUNE GROUP2.17%$13.45+1.6%
13RLAYRELAY THERAPEUTICS2.06%$18.49+2.4%
14TVTXTRAVERE THERAPEUTICS2.17%$56.85-3.4%
15OSCROSCAR HEALTH1.98%$29.90-3.0%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.

Sign in to see all 60
Sector weights
Healthcare96.1%
Health Technology77.09%
Health Services13.54%
Commercial Services5.21%
Consumer Discretionary2.77%
Consumer Defensive2.7%
Electronic Technology2.44%
Financial Services1.2%
Financials1.19%
Finance0.79%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Country weights
United States98.17%
Bermuda2.2%
Switzerland1.85%
Netherlands1.83%
Other0.16%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Performance
1 week-3.1%
1 month-2.1%
3 months-0.8%
6 months+28.5%
YTD+20.0%
1 year+34.7%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$79M
1 month+$99M
3 months+$229M
YTD+$225M
1 year+$225M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows
JulAugSepOctFebMarAprMayJunJulAugSep
DAILY CREATION/REDEMPTION RECORDS, TRAILING TWELVE MONTHS
The risk read
20%realized volatility, 30 days (annualized)
26%realized volatility, 1 year
-14.6%deepest fall from a peak, 1 year
-6.9%latest close versus that peak

The top holding is 6.4% of the book; the top ten carry 41%. Spread across 55+ names, it behaves like roughly 37 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
—calls · latest snapshot
—puts · latest snapshot
—put/call ratio
55Kshares traded
Most-traded holdings, options premiumBullishBearish
MRNA MODERNA$35M$34M
LQDA LIQUIDIA$13M$17M
HUM HUMANA$8M$7M
HIMS HIMS & HERS HEALTH$2M$3M
TWST TWIST BIOSCIENCE$1M$1M

TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES

The case against PTH

Due diligence cuts both ways. These funds sit on the same shelf and beat PTH on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW State Street SPDR Portfolio Developed World ex-US ETF0.03%$41.5B+$286M-57bp on fee · 113× the assets · +$286M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.2B+$199M-57bp on fee · 50× the assets · +$199M in over the monthHead-to-head
SPYG State Street SPDR Portfolio S&P 500 Growth ETF0.04%$56.2B+$717M-56bp on fee · 153× the assets · +$717M in over the monthHead-to-head
SPYV State Street SPDR Portfolio S&P 500 Value ETF0.04%$36.2B+$208M-56bp on fee · 99× the assets · +$208M in over the monthHead-to-head
IUSG iShares Core S&P U.S. Growth ETF0.04%$34.3B+$148M-56bp on fee · 93× the assets · +$148M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
InstrumentsHarvest substitutesTrade cost at $1MClient tearsheetStress this fund
Every weekday · 6:30 a.m. ET

The Morning Brief

The private wealth industry in four minutes, every weekday at 6:30 a.m. ET. Free.